Bøger i Drug Discovery serien

This book aims to provide a comprehensive examination of the field of molecular chaperone inhibition and its application to pharmaceutical research.

A focussed and engaging book capturing tactical aspects of problem solving in antiviral drug design.

Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area.

This book provides an up-to-date monograph on the drug discovery and regulatory elements of therapuetics used to treat rare or "orphan" diseases.

An exciting volume that provides a comprehensive and up-to-date review on the potential of peptides and proteins from animal venoms as human therapeutics.

This exemplary new book reviews some of the most outstanding examples of new drugs currently in pharmaceutical development or new targets under the validation process to try to reach the Parkinsons drug market in the next few years as potential disease modifying drugs.

This book presents a contemporary review of the field of Pain Therapeutics, including the historical medicines which still dominate standard of care treatments, as well as new mechanisms and combinations/reformulations that have dominated the regulatory approvals over the last decade.

This book will provide an overview of the chemistry of nanocarrier design and the considerations that need to be made when developing a nanomedicine.

Focussing on drug discovery from key targets, this book comprehensively covers the new and recent discoveries in the area of carbohydrate drug discovery.

This book will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in drug discovery techniques.

This book will provide an invaluable guide to epigenetics, one of the fastest moving fields in drug discovery, for medicinal chemists working in academia and in the pharmaceutical industry.

This book thoroughly explores the predictive role of drug metabolism and pharmacokinetics in drug discovery and in improving success rates and safety assessments of chemicals.

This book comprehensively reviews current knowledge and techniques in the transporter sciences and their relations to drug metabolism and pharmacokinetics.

This book provides a complete picture of drug discovery for these inter-related conditions by bringing together the latest information and highlighting links between them.

This book addresses the various classes of privileged scaffolds and covers the history of their discovery and use.

This book covers new insights in the field of schizophrenia with an aim to advance the understanding of scientists and clinicians in this area and to fuel drug discovery.

Anti-Inflammatory Drug Discovery provides a comprehensive review of recent medicinal chemistry approaches to a variety of important therapeutic targets

The aim of this book is to provide a state of the art review on investigations into Nuclear Receptors

This book covers proteomics biomarker discovery and validation procedures from the clinical perspective.

This book is a state-of-the art review of new therapeutic strategies towards treatments for T2D.

Examines current and prospective biomarkers for assessment of traumatic brain injury using a multidisciplinary approach involving biochemistry, molecular biology and clinical chemistry.

This book provides a critical overview of the advances being made towards overcoming biological barriers through the contribution of nanosciences and nanotechnologies.

This is the first book to pull together studies and reviews from cutting edge authors who work in the emerging and exciting field of multi-targeted drug discovery.

Provides an updated view of the current challenges faced by computational tools to decipher the basis of ligand-receptor interaction and modeling of biomolecular systems and drug discovery.

Emerging Drugs and Targets for Alzheimer's Disease collects some of the most outstanding examples of new drugs currently in pharmaceutical development or new targets under the validation process that will reach the Alzheimer's drug market over the next few years as disease modifying drugs.

The focus of this new book is for medicinal chemists on the chemical agents that have been used, or might be required in the future, and the methods of synthesis for inserting the reporter groups. A key reference for academics, postgraduates, researchers, industrialists and professionals working in or joining this field.

This book will act as a primer for graduates and postgraduates interested in a career in drug discovery. It covers both synthetic technologies currently impacting medicinal chemistry and emerging areas.

An invaluable guide to successful practice in neglected tropical diseases (NTDs) and highlights best practice to guide the ongoing drug discovery effort.

This is the first comprehensive description of the discovery and therapeutic potential of polyamine drugs.

A rapidly growing field, this book covers the recent advances in screening technology, ion channel structure and modelling, with up-to-date case histories.